{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:22:17Z","timestamp":1769156537832,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,10,10]],"date-time":"2012-10-10T00:00:00Z","timestamp":1349827200000},"content-version":"vor","delay-in-days":283,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012]]},"DOI":"10.6061\/clinics\/2012(10)12","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T15:30:57Z","timestamp":1349105457000},"page":"1197-1202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacokinetics of cyclosporin - a microemulsion in children with idiopathic nephrotic syndrome"],"prefix":"10.1016","volume":"67","author":[{"given":"Luciana","family":"dos Santos Henriques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fab\u00edola","family":"de Marcos Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena","family":"Vaisbich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.6061\/clinics\/2012(10)12_bib1","first-page":"4","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone","volume":"98","year":"1981","journal-title":"J Pediatr"},{"issue":"12","key":"10.6061\/clinics\/2012(10)12_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.ki.5002553","article-title":"Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations","volume":"72","author":"Cattran","year":"2007","journal-title":"Kidney Int"},{"issue":"3","key":"10.6061\/clinics\/2012(10)12_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11096-010-9380-2","article-title":"Pharmacotherapeutic review and uptade of idiopathic nephrotic syndrome in children","volume":"32","author":"Manrique-Rodr\u00edguez","year":"2010","journal-title":"Pharm World Sci"},{"issue":"2","key":"10.6061\/clinics\/2012(10)12_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MOP.0b013e3282f4e6e4","article-title":"Evaluation and management of steroid-unresponsive nephrotic syndrome","volume":"20","author":"Del Rio","year":"2008","journal-title":"Curr Opin Pediatr"},{"issue":"9384","key":"10.6061\/clinics\/2012(10)12_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.6061\/clinics\/2012(10)12_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00467-008-0771-8","article-title":"Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome","volume":"23","author":"S\u00fcmegi","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.6061\/clinics\/2012(10)12_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00467-004-1618-6","article-title":"Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome","volume":"20","author":"Rinaldi","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.6061\/clinics\/2012(10)12_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfi059","article-title":"Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience","volume":"20","author":"El-Husseini","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.6061\/clinics\/2012(10)12_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/cyto.1997.0210","article-title":"Suppression of dialysis patients' lymphocyte IL-2R expression by glucocorticoids and cyclosporine","volume":"9","author":"Briggs","year":"1997","journal-title":"Cytokine"},{"key":"10.6061\/clinics\/2012(10)12_bib10","first-page":"85","article-title":"Molecular mechanisms of the immunosuppressive action of cyclosporin A","volume":"19(9\u201310)","author":"Resch","year":"1997","journal-title":"Int J Immunopharmacol"},{"issue":"3","key":"10.6061\/clinics\/2012(10)12_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000189558","article-title":"Antiproteinuric effect of ciclosporin A in adriamycin nephropathy in rats","volume":"75","author":"Desassis","year":"1997","journal-title":"Nephron"},{"issue":"9","key":"10.6061\/clinics\/2012(10)12_bib12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"issue":"5","key":"10.6061\/clinics\/2012(10)12_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1139\/Y07-025","article-title":"Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats","volume":"85","author":"Medeiros","year":"2007","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"10.6061\/clinics\/2012(10)12_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00007691-200408000-00012","article-title":"Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection","volume":"26","author":"Weber","year":"2004","journal-title":"Ther Drug Monit"},{"issue":"9","key":"10.6061\/clinics\/2012(10)12_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.transproceed.2004.10.015","article-title":"Identifying cyclosporine blood levels associated with the prevention of renal transplant rejection: a single-center, randomized prospective study","volume":"36","author":"Britto","year":"2004","journal-title":"Transplant Proc"},{"issue":"1","key":"10.6061\/clinics\/2012(10)12_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00467-006-0300-6","article-title":"Decreased cyclosporine exposure during the remission of nephrotic syndrome","volume":"22","author":"Medeiros","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.6061\/clinics\/2012(10)12_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"10.6061\/clinics\/2012(10)12_bib18","unstructured":"Abbott Laboratories. TDxFLx cyclosporine monoclonal whole blood. Package insert 9797-60 E 34-0060\/R7 2001:1-6 Abbott Laboratories Abbott Park, IL"},{"issue":"18","key":"10.6061\/clinics\/2012(10)12_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2169\/internalmedicine.47.1088","article-title":"Monitoring of blood cyclosporine concentration in steroid-resistant nephrotic syndrome","volume":"47","author":"Naito","year":"2008","journal-title":"Intern Med"},{"issue":"6","key":"10.6061\/clinics\/2012(10)12_bib20","first-page":"1040","article-title":"Cyclosporin \u2013 a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders","volume":"45","author":"Faulds","year":"1993","journal-title":"Drugs"},{"issue":"7","key":"10.6061\/clinics\/2012(10)12_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00467-005-1844-6","article-title":"Cyclosporin A absorption profiles in children with nephrotic syndrome","volume":"20","author":"Nozu","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.6061\/clinics\/2012(10)12_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s004670050570","article-title":"Cyclosporine A monitoring in children: abbreviated area under curve formulas and C2 level","volume":"13","author":"Dello Strologo","year":"1999","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.6061\/clinics\/2012(10)12_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00007691-199704000-00004","article-title":"Cyclosporin A trough levels correlate with serum lipoproteins and apolipoproteins: implications for therapeutic drug monitoring of cyclosporin A","volume":"19","author":"Von Ahsen","year":"1997","journal-title":"Ther Drug Monit"},{"issue":"10","key":"10.6061\/clinics\/2012(10)12_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ki.2008.24","article-title":"Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter Trial","volume":"73","author":"Ishikura","year":"2008","journal-title":"Kidney Int"},{"key":"10.6061\/clinics\/2012(10)12_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/clinchem\/42.8.1294","article-title":"Abbreviated area-under-the-curve strategy for monitoring cyclosporin microemulsion therapy in immediate posttransplant period","volume":"42","author":"Amante","year":"1996","journal-title":"Clin Chem"},{"issue":"2","key":"10.6061\/clinics\/2012(10)12_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1399-3046.2005.00436.x","article-title":"Cyclosporine drug monitoring with C0 and C2 concentrations in children with stable renal allograft function","volume":"10","author":"Kalyoncu","year":"2006","journal-title":"Pediatr Transplant"},{"issue":"7","key":"10.6061\/clinics\/2012(10)12_bib27","first-page":"5","article-title":"Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study","volume":"81","author":"Kyll\u00f6nen","year":"2006","journal-title":"Transplantation"},{"issue":"5","key":"10.6061\/clinics\/2012(10)12_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1399-3046.2005.00339.x","article-title":"Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients","volume":"9","author":"Strong","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.6061\/clinics\/2012(10)12_bib29","first-page":"5","article-title":"Evolution of the therapeutic drug monitoring of cyclosporine","volume":"36","author":"Critterio","year":"2004","journal-title":"Trasnplant Proc"},{"key":"10.6061\/clinics\/2012(10)12_bib30","first-page":"11","article-title":"Clinical validation studies of Neoral C(2) monitoring: a review","volume":"73(9Suppl)","author":"Nashan","year":"2002","journal-title":"Transplantation"},{"issue":"9","key":"10.6061\/clinics\/2012(10)12_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007890-199911150-00023","article-title":"The temporal profile of calcineurin inhibition by cyclosporine in vivo","volume":"68","author":"Halloran","year":"1999","journal-title":"Transplantation"},{"issue":"4","key":"10.6061\/clinics\/2012(10)12_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1034\/j.1600-6143.2001.10407.x","article-title":"Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine","volume":"1","author":"Kung","year":"2001","journal-title":"Am J Transplant"},{"key":"10.6061\/clinics\/2012(10)12_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/FTD.0b013e3181c0eecb","article-title":"Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives","volume":"32","author":"Van Rossum","year":"2010","journal-title":"Ther Drug Monit"},{"issue":"5","key":"10.6061\/clinics\/2012(10)12_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1373\/clinchem.2009.138693","article-title":"Counterpoint: Is pharmacokinetic or pharmacodynamic monitoring of calcineurin inhibition therapy necessary","volume":"56","author":"Marquet","year":"2010","journal-title":"Clin Chem"},{"issue":"9","key":"10.6061\/clinics\/2012(10)12_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2217\/pgs.11.70","article-title":"Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients","volume":"12","author":"Santoro","year":"2011","journal-title":"Pharmacogenomics"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222022220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222022220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-10\/cln-67-10-1197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:11:00Z","timestamp":1761721860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222022220"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322012001000012&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3460023\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"alternative-id":["S1807593222022220"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(10)12","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of cyclosporin - a microemulsion in children with idiopathic nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(10)12","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}